Development and validation of the gastric risk immuno-progression score (GRIPS) in advanced gastric and gastroesophageal junction adenocarcinoma treated with first-line chemotherapy plus nivolumab: Results from the ORACLE study

Pretta, Andrea;Scartozzi, Mario
Last
Supervision
2025-01-01

2025
Inglese
Journal of Clinical Oncology - Meeting Abstract: 2025 ASCO Annual Meeting I
LIPPINCOTT WILLIAMS & WILKINS
TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
43
16_suppl
4062
4062
1
2025 ASCO Annual Meeting
Esperti anonimi
29 Maggio - 2 Giugno 2025
Chicago
scientifica
Goal 3: Good health and well-being
no
4 Contributo in Atti di Convegno (Proceeding)::4.1 Contributo in Atti di convegno
Spanu, Dario; Ziranu, Pina; Pretta, Andrea; Cerantola, Riccardo; Salani, Francesca; Ortolani, Silvia; Di Giacomo, Emanuela; D'Agata, Alessandra Pia; G ...espandi
273
20
4.1 Contributo in Atti di convegno
none
info:eu-repo/semantics/conferencePaper
Files in This Item:
There are no files associated with this item.

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Questionnaire and social

Share on:
Impostazioni cookie